Replies to post #712627 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Your inability to understand how biotech and the approval of a drug for a certain cancer indication works does not surprise me at all.
You already showed to not know much about the workings of an RA approval process.
NWBO should count its lucky stars if it gets FDA-approved for GBM n and r (which I think is possible but not certain) in the US the way the DCVAXL trial SAP has been set up.

A universal cancer vaccine can only be proven with multi-medical trials which NWBO has shown not to be capable of conducting.
Several immu biotech companies actually are in multi-medical trials and have already had RA-approved indications. That is because these biotech companies are well-led by management that delivers shareholders AND patient value. Not so much this inept management.

The rest is just wishful thinking fantasy.

[dennisdave]

Unlikely you, I have never claimed anything else that is not consistent with reality.
Quote me where I said DCVAXL is NOT constructed as a universal cancer vaccine I never claimed that you claimed that I said that.

I unlikely you live in reality and in reality where DCVAX has yet to be proven to be effective for any other cancer indication than DBM r and n. I personally don't think this management team will ever be capable and able to conduct any new cancer indication trial something they are claiming they will start any day now for many many years.

Your claim that DCVAXL will be automatically approved by the FDA, after the UK has approved DCVAL, is false and misleading.

But I understand why people such as yourself are not capable of living in reality.